SR59230A
CAS No. 174689-39-5
SR59230A ( —— )
Catalog No. M21725 CAS No. 174689-39-5
SR59230A is a potent, selective, and blood-brain barrier penetrating β3-adrenergic receptor antagonist with IC50s of 40, 408, and 648 nM for β3, β1, and β2 receptors, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 63 | In Stock |
|
5MG | 98 | In Stock |
|
10MG | 164 | In Stock |
|
25MG | 325 | In Stock |
|
50MG | 483 | In Stock |
|
100MG | 698 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSR59230A
-
NoteResearch use only, not for human use.
-
Brief DescriptionSR59230A is a potent, selective, and blood-brain barrier penetrating β3-adrenergic receptor antagonist with IC50s of 40, 408, and 648 nM for β3, β1, and β2 receptors, respectively.
-
DescriptionMDMA (20 mg/kg) produces a slowly developing hyperthermia, reaching a maximum increase of 1.8°C at 130 min post injection. SR59230A (0.5 mg/kg) produces a small but significant attenuation of the slowly developing hyperthermia to MDMA. SR59230A (5 mg/kg) reveals a significant and marked early hypothermic reaction to MDMA.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number174689-39-5
-
Formula Weight415.48
-
Molecular FormulaC23H29NO6
-
Purity>98% (HPLC)
-
SolubilityDMSO : 31.25 mg/mL (75.21 mM; Need ultrasonic)
-
SMILESO[C@@H](CN[C@H]1CCCC2=C1C=CC=C2)COC3=CC=CC=C3CC.O=C(O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nisoli E, et al. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.Mol Pharmacol. 1996 Jan;49(1):7-14.
2. Kanzler SA, et al. Involvement of β3-adrenergic receptors in the control of food intake in rats.Braz J Med Biol Res. 2011 Nov;44(11):1141-7.
3. Bruno G, et al. β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P2 modulation.Oncogene. 2020 Jan;39(2):368-384.
molnova catalog
related products
-
BRL 44408 maleate
A potent, selective α2A-adrenoceptor antagonist with Ki of 1.7 nM, 80-fold selectivity over α2B-adrenergic receptors.
-
Flavone
Flavons have effects on CYP (P450) activity which are enzymes that metabolize most drugs in the body.
-
Higenamine
Higenamine is a novel α1 -adrenoceptor antagonist.